Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Thumbnail

Study finds immediate access to radiology results eases oncology patients' anxiety

The findings show most patients prefer discussing sensitive imaging results with their healthcare provider in a timely manner.

ovaries ovarian cancer

Pretargeted radioimmunotherapy shows early promise in treating aggressive ovarian cancer

The new-look nuclear medicine treatment was able to cure advanced ovarian cancer in some mice, with limited side effects.

Souvik Roy UTA

'Robust' new imaging technique combines ultrasound with optical tomography

Researchers with the University of Texas at Arlington received a grant worth $190,000 to continue working on the new modality. 

Thumbnail

Preop prostate MRI findings predict cancer recurrence at rates similar to pathology, analysis shows

Given the similarities in accuracy between pathology results and preoperative imaging, MRI could have a greater role in risk assessments in the future, experts suggested in AJR.

Thumbnail

SPECT/CT helps personalize treatment options for prostate cancer patients

Using SPECT/CT imaging, providers can stratify patients based on their treatment responses and make personalized adjustments accordingly.

whole-body pet scanner add-on device presented at #SNMMI 2023

New PET technology offers 'clear improvement' of whole-body scan resolution

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

Thumbnail

New prostate cancer PET imaging agent officially available for commercial use

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.

Thumbnail

Prostate cancer size is frequently underestimated on imaging

Newly published data recently revealed just how common the extent of prostate cancer is underestimated based on imaging measurements. 

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup